nalbuphine HCl ER

Drug identity checked against registry records

Also recorded as nalbuphine

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic PruritusNCT02143973Trevi TherapeuticsPhase 2, Phase 3Completed2016-01Actual
Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo NodularisNCT02174432Trevi TherapeuticsPhase 2, Phase 3Completed2017-09-03Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.